SCHEMBL16976074

SCHEMBL16976074

CSCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](C)CCCCN)C(=O)N[C@H](C(=O)N[C@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(N)=O)[C@@H](C)O

nearest known ligand 0.57

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ GLP1R P43220 1/20 0.57
▸ GCGR P47871 1/20 0.57
▸ GIPR P48546 1/20 0.57
▸ IL23R Q5VWK5 2/20 0.56
▸ NPY4R P50391 11/20 0.56
▸ NPY1R P25929 7/20 0.56
▸ NPY2R P49146 6/20 0.56
▸ NPY5R Q15761 6/20 0.56
▸ TFPI P10646 1/20 0.56
▸ KISS1R Q969F8 3/20 0.53
▸ BCL2L1 Q07817 1/20 0.53
▸ BAD Q92934 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15185865 1.00 GLP1R (0.57) GLP1RGCGRGIPRIL23RNPY4R
SCHEMBL16976095 1.00 GLP1R (0.57) GLP1RGCGRGIPRIL23RNPY4R
SCHEMBL16976124 1.00 GLP1R (0.57) GLP1RGCGRGIPRIL23RNPY4R
SCHEMBL16976127 1.00 GLP1R (0.57) GLP1RGCGRGIPRIL23RNPY4R
SCHEMBL14479453 1.00 GLP1R (0.57) GLP1RGCGRGIPRIL23RNPY4R
SCHEMBL16976126 1.00 GLP1R (0.57) GLP1RGCGRGIPRIL23RNPY4R
SCHEMBL14479340 0.99 GLP1R (0.56) GLP1RGCGRGIPRIL23RNPY4R
SCHEMBL16976099 0.98 GLP1R (0.57) GLP1RGCGRGIPRIL23RNPY4R
SCHEMBL16976070 0.98 GLP1R (0.60) GLP1RGCGRGIPRIL23RNPY4R
SCHEMBL14479349 0.97 GLP1R (0.56) GLP1RGCGRGIPRIL23RNPY4R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9096646-B2 CXCR4 receptor compounds ANCHOR THERAPEUTICS, INC. (US) 2015-08-04 — — US disclosed
Send feedback